Rotman Harris

Officer at CNTA

Sold, on record
$270k
Dollars the filings state
Form 4 sales
2
Latest Feb 1, 2024
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CNTACentessa Pharmaceuticals plcOfficer

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 144 notice CNTANotice
    Sep 20, 2023 2023

    Filed to sell 37,484 shares ($244k)

    Rotman Harris, Officer

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale CNTARoutine
    Sep 20, 2023 same day

    Sold 37,484 shares at $6.29 ($236k)

    Rotman Harris, SVP Regulatory Affairs

    10b5-1 planSold 52.8% of holdings ($446k position)33,500 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice CNTANotice
    Feb 1, 2024 +134 days

    Filed to sell 4,267 shares ($35k)

    Rotman Harris, Officer

    10b5-1 planFiling

  4. 4 Form 4 sale CNTARoutine
    Feb 1, 2024 same day

    Sold 4,267 shares at $8.10 ($35k)

    Rotman Harris, SVP Regulatory Affairs

    10b5-1 planSold 6.4% of holdings ($542k position)62,625 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Rotman Harris
Source
Feb 1, 2024Feb 2, 2024CNTASVP Regulatory AffairsForm 4 sale4,267$35k6.4%RoutineSEC
Feb 1, 2024Feb 1, 2024CNTAOfficerForm 144 notice4,267$35kNoticeSEC
Sep 20, 2023Sep 22, 2023CNTASVP Regulatory AffairsForm 4 sale37,484$236k52.8%RoutineSEC
Sep 20, 2023Sep 20, 2023CNTAOfficerForm 144 notice37,484$244kNoticeSEC